FFuzkk Atlas of China
#272FUZKK selection 101–1000

亿一生物制药(北京)有限公司

亿一生物制药(北京)有限公司

#272

Biologics

Manufacturing profile

Biologics

Selection basis

The company was selected from a public production/supply universe as a legal entity with strong pharmaceutical-manufacturing indicators. Positions 101–1000 are FUZKK atlas priorities, not an official revenue ranking.

Score
185
Public source order
2419
The FUZKK fit shows potential applicability of existing utilities. It does not claim actual use of FUZKK, specific installed equipment models or a product not confirmed by the public company profile.

Representative manufacturing and QC chain

  1. 1Cell bank or microbial seed
  2. 2Upstream culture or fermentation
  3. 3Clarification and chromatography
  4. 4UF/DF, formulation and sterile filtration
  5. 5SEC, CE, LC-MS, ELISA, qPCR and bioassay QC

Relevant FUZKK packages

Global API & Biosimilars QC SuiteLabEx QC Suite

Product/API utilities

Residual Host Cell DNA Quality CheckerResidual Host Protein Checker

Lumex — instrumental QC

CE Glycosylation Profiler

LabEx — laboratory QC

Biologic Aggregate Size Quality CheckerCharge Variant CE Quality CheckerProtein Concentration UV Quality CheckerELISA Bioassay Quality CheckerSPR Binding Affinity Quality CheckerEndotoxin Biologic Product Quality CheckerAutomated Sterility Detection Quality Checker

Medical Devices — equipment and software lifecycle

Supplier Evaluation CheckerCalibration Status CheckerProcess Validation CheckerChange Control Impact CheckerRequirement Traceability CheckerData Integrity Security Checker

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand the scope.

Mapping boundary

The FUZKK fit shows potential applicability of existing utilities. It does not claim actual use of FUZKK, specific installed equipment models or a product not confirmed by the public company profile.

Methodology